Revenue Recognition Principles Negatively Impact The Biotechnology Industry, New Study Confirms
Current revenue recognition accounting principles continue to place unnecessary challenges on small and medium-sized biotechnology companies who enter into collaborative arrangements, according to an independent study released today by the Biotechnology Industry Organization (BIO). The study, entitled "Revenue Recognition for Collaborative Arrangements in the Biotechnology Industry, was conducted by Glass, Lewis, & Co., LLC, a leading research and professional services firm.
Source: www.medicalnewstoday.com

Wisconsin's Biotechnology & Medical Device Association Applauds Historic Genomic Research Initiative
The following is a statement by Jim Leonhart, executive director of the Wisconsin Biotechnology & Medical Device Association, regarding this morning's announcement by Gov. Jim Doyle of the Wisconsin Genomics Initiative. The initiative is a public-private partnership that includes Marshfield Clinic, the Medical College of Wisconsin, the University of Wisconsin School of Medicine and Public Health, and UW-Milwaukee. "Today's historic announcement by Gov.
Source: www.medicalnewstoday.com

Walgreen Co. Announces Retirement Of Jeffrey Rein As Chairman And CEO - Board Names Alan McNally Chairman And Acting CEO
Walgreens (NYSE:WAG)(NASDAQ:WAG) today announced that Jeffrey A. Rein, 56, is retiring as Chairman, Chief Executive Officer and a director. Alan G. McNally, 62, lead director of the Walgreens Board, has been named Chairman and acting Chief Executive Officer. Mr. McNally previously served as chairman and CEO of Harris Bankcorp and has been a member of the Walgreens Board since 1999.
Source: www.medicalnewstoday.com

Partnership To Develop Next Generation Of HIV Vaccines
Elevation Biotech, a start-up biotechnology company funded by LIFElab, an agency of the South African Department of Science and Technology, and the International AIDS Vaccine Initiative (IAVI), the world's only global non-profit organization dedicated solely to AIDS vaccine development, have partnered to develop the next generation of AIDS vaccine candidates. "An AIDS vaccine remains our best hope for ending AIDS.
Source: www.medicalnewstoday.com

Leading Drug Database To Be Housed At U-M
The University of Michigan received $5 million from the National Institutes of Health to develop the world's leading resource of high-quality experimental data sets of drug-making compounds that will ultimately take computer-aided drug design to a new level. The resource will house the data needed to improve computer programs that can predict the effectiveness of potential new drugs, said Heather Carlson, associate professor in the U-M College of Pharmacy and Medicinal Chemistry.
Source: www.medicalnewstoday.com

Drug Companies Plan To Invest In HIV/AIDS Drug Development, Improve Access, U.N. Secretary-General Says
United Nations Secretary-General Ban Ki-moon on Thursday said that many large pharmaceutical companies -- including Abbott Labs, Boehringer Ingelheim, GlaxoSmithKline and Pfizer -- plan to increase their efforts to develop HIV/AIDS drugs and diagnostics for impoverished regions, Reuters reports.
Source: www.medicalnewstoday.com

University Of Brighton And National Pharmacy Association Team Up To Offer "University Interact", UK
The NPA Interact Course for Medicines Counter Assistants (University Interact) has been adapted and is now included as a part of the undergraduate teaching for first year pharmacy students at Brighton University - a UK first. The theory learned at University will ease entry into the world of pharmacy when students apply their knowledge in term time placements and summer jobs.
Source: www.medicalnewstoday.com

Amgen Issues Statement On Court Of Appeals Ruling That Affirms Preliminary Injunction Against Roche
The United States (U.S.) Court of Appeals for the Federal Circuit has issued a ruling that affirms the preliminary injunction ordered by the U.S. District Court in Boston barring Roche from selling its pegylated-erythropoietin (peg-EPO) product MIRCERA in the U.S.
Source: www.medicalnewstoday.com

California Pharmacists Association Urges Consumers To Talk To Their Pharmacist During American Pharmacists Month
This year alone more than one in every 200 Americans will experience injury or death because of medications. Many of these problems occur in a place we least expect - our homes. The home is where the most medications are taken with the least amount of medical supervision. American Pharmacists Month provides patients and pharmacists with an opportunity to reduce this risk and improve medication outcomes through dialogue. Recently, the U.S.
Source: www.medicalnewstoday.com